Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease

Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease

Stem cell therapy is a promising treatment for incurable disorders including Huntington's disease (HD). Adipose-derived stem cell (ASC) is an easily available source of stem cells. Since ASCs can be differentiated into nervous stem cells, it has clinically feasible potential for neurodegenerati...

Full description

Bibliographic Details
Main Authors:	Im, Wooseok, Ban, Jaejun, Lim, Jiyeon, Lee, Mijung, Lee, Soon-Tae, Chu, Kon, Kim, Manho
Format:	Online
Language:	English
Published:	Public Library of Science 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614936/

Similar Items

Sun Ginseng Protects Endothelial Progenitor Cells From Senescence Associated Apoptosis
by: Im, Wooseok, et al.
Published: (2012)

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model
by: Im, Wooseok, et al.
Published: (2015)

MicroRNA-124 slows down the progression of Huntington’s disease by promoting neurogenesis in the striatum
by: Liu, Tian, et al.
Published: (2015)

Cell Therapy Strategies vs. Paracrine Effect in Huntington’s Disease
by: Im, Wooseok, et al.
Published: (2014)

Neurogenic Effects of Cell-Free Extracts of Adipose Stem Cells
by: Ban, Jae-Jun, et al.
Published: (2016)

A Case of Juvenile Huntington Disease in a 6-Year-Old Boy
by: Sunwoo, Jun-Sang, et al.
Published: (2010)

Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
by: Park, Jung-Eun, et al.
Published: (2013)

Suitability of autologous serum for expanding rabbit adipose-derived stem cell populations
by: Bahn, Jae-Jun, et al.
Published: (2012)

In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington’s Disease
by: Jeon, Iksoo, et al.
Published: (2014)

Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
by: Im, Wooseok, et al.
Published: (2016)

Epicardial adipose excision slows the progression of porcine coronary atherosclerosis
by: McKenney, Mikaela L, et al.
Published: (2014)

MicroRNAs in Experimental Models of Movement Disorders
by: Lee, Soon-Tae, et al.
Published: (2011)

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease
by: Paganini, Marco, et al.
Published: (2014)

Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model
by: Kim, Jeong-Min, et al.
Published: (2014)

Computers in Personnel: Slow Progress
by: Derek, Torrington, et al.
Published: (1985)

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease
by: McCourt, Andrew C., et al.
Published: (2016)

Can We Slow Down the Global Increase of Adiposity?
by: Schwandt, Peter
Published: (2011)

Mechanisms of Copper Ion Mediated Huntington's Disease Progression
by: Fox, Jonathan H., et al.
Published: (2007)

Factors contributing to clinical picture and progression of Huntington's disease
by: Daniel Zielonka
Published: (2018-01-01)

Respiratory decline is integral to disease progression in Huntington's disease
by: Jones, Una, et al.
Published: (2016)

Double trouble progressive external ophthalmoplegia and Huntington's disease☆
by: Finsterer, Josef, et al.
Published: (2016)

Improvement of Cognitive Deficit in Alzheimer’s Disease Patients by Long Term Treatment with Korean Red Ginseng
by: Heo, Jae-Hyeok, et al.
Published: (2011)

Shunting in AD slows progression of the dementia
by: Silverberg Gerald D, et al.
Published: (2007-12-01)

Slowing progression of chronic kidney disease
by: Drawz, Paul E, et al.
Published: (2013)

Progressive Impairment of Lactate-based Gluconeogenesis in the Huntington’s Disease Mouse Model R6/2
by: Nielsen, Signe Marie Borch, et al.
Published: (2015)

Striatal Pre-Enkephalin Overexpression Improves Huntington’s Disease Symptoms in the R6/2 Mouse Model of Huntington’s Disease
by: Bissonnette, Stéphanie, et al.
Published: (2013)

Vitamin A deficiency: slow progress towards elimination
by: Davidson H Hamer, et al.
Published: (2015-09-01)

The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia
by: Lei Wan, et al.
Published: (2018-09-01)

Pakistan's slow progress towards gender parity
by: Ariba Moin, et al.
Published: (2018-02-01)

Women in Corporate Management in Canadian Organizations: Slow Progress?
by: Ronald J., Burke
Published: (1994)

Does erythropoietin slow progression of chronic kidney disease?
by: Nasri, Hamid, et al.
Published: (2013)

Atg4b-Dependent Autophagic Flux Alleviates Huntington’s Disease Progression
by: Proenca, Catia C., et al.
Published: (2013)

Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease
by: Atherton, Jeremy F, et al.
Published: (2016)

Potential biomarkers to follow the progression and treatment response of Huntington’s disease
by: Disatnik, Marie-Hélène, et al.
Published: (2016)

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression
by: de Diego-Balaguer, Ruth, et al.
Published: (2016)

Reply to: Double trouble progressive external ophthalmoplegia and Huntington's disease
by: Filosto, Massimiliano, et al.
Published: (2016)

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood
by: Mastrokolias, Anastasios, et al.
Published: (2015)

Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
by: Tousley, Adelaide, et al.
Published: (2016)

Two-Point Magnitude MRI for Rapid Mapping of Brown Adipose Tissue and Its Application to the R6/2 Mouse Model of Huntington Disease
by: Lindenberg, Katrin S., et al.
Published: (2014)

Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
by: Gil, Joana MAC, et al.
Published: (2004)